Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 7 Non-Muscle Invasive Bladder Neoplasms 5 Multiple Myeloma 4 Glioma 4 Carcinoma, Transitional Cell 4 Prostatic Neoplasms 3 Neoplasms 3 Wilms Tumor 2 Urothelial Cancer 2 Rhabdoid Tumor 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lung Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Esophageal Neoplasms 2 Ependymoma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Acrocephalosyndactylia 2 Xanthogranuloma, Juvenile 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1

Interventions

Injections 26 toripalimab 17 pembrolizumab 17 tislelizumab 12 Gemcitabine 8 Cisplatin 7 spartalizumab 6 atezolizumab 6 Irinotecan 6 Carboplatin 6 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 Leucovorin 5 Fluorouracil 5 camrelizumab 4 Pemetrexed 4 Docetaxel 4 Cetuximab 4 Capecitabine 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 lenvatinib 3 cediranib 3 PM 01183 3 Drug Therapy 3 Cyclophosphamide 3 Bevacizumab 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × erdafitinib × Clear all

NCT04083976 2026-05-04

RAGNAR

Janssen Research & Development, LLC

Phase 2 Completed

316 enrolled 15 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡